Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lesaka Technologies, Inc. (“Lesaka” or “the Company”) (NASDAQ: LSAK). Investors who purchased Lesaka securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Lesaka has violated federal securities laws.

Investigation Details

On September 10, 2025, Lesaka announced in an SEC filing that the Audit Committee of its Board of Directors “concluded that the Company’s unaudited condensed consolidated financial statements for the quarters ended September 30, 2024, December 31, 2024, and March 31, 2025, respectively, included in the Company’s Quarterly Reports on Form 10-Q for the quarters ended September 30, 2024, December 31, 2024, and March 31, 2025, respectively (the “Quarterly Reports”), should be restated, and that such unaudited condensed financial statements should no longer be relied upon, due to the Company’s re-evaluation of the classification of certain revenue that has been reported as an agent rather than as principal, and related cost of goods sold.” Following this news, Lesaka’s stock dropped.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Lesaka securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660